Anagrelide hydrochloride and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Anagrelide hydrochloride and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: anagrelide
Brand name: Agrylin
Synonyms: Anagrelide
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Anagrelide hydrochloride-Insulin glargine, recombinant Subcutaneous
- Anagrelide hydrochloride-Insulin glulisine
- Anagrelide hydrochloride-Insulin Glulisine (Cartridges and Pens)
- Anagrelide hydrochloride-Insulin Glulisine (Vials)
- Anagrelide hydrochloride-Insulin glulisine Subcutaneous
- Anagrelide hydrochloride-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Anakinra
- Insulin glargine and lixisenatide Subcutaneous-Anakinra Subcutaneous
- Insulin glargine and lixisenatide Subcutaneous-Analgesic Balm Greaseless
- Insulin glargine and lixisenatide Subcutaneous-Analpram Advanced
- Insulin glargine and lixisenatide Subcutaneous-Analpram E
- Insulin glargine and lixisenatide Subcutaneous-Analpram E Cream